257 related articles for article (PubMed ID: 26524350)
41. The predictive value of positive and suspicious urine cytology: Are they different?
Kuan KC; Segura SE; Ahlstedt J; Khader SN; Hakima L
Diagn Cytopathol; 2020 Nov; 48(11):998-1002. PubMed ID: 32558388
[TBL] [Abstract][Full Text] [Related]
42. Cytological significance of abnormal squamous cells in urinary cytology.
Hattori M; Nishimura Y; Toyonaga M; Kakinuma H; Matsumoto K; Ohbu M
Diagn Cytopathol; 2012 Sep; 40(9):798-803. PubMed ID: 21309015
[TBL] [Abstract][Full Text] [Related]
43. Cell blocks in urine cytopathology: do they add value to the diagnosis? A pilot study.
Wilson BL; Russell D; Evans SK; Agrawal T
J Am Soc Cytopathol; 2021; 10(1):47-55. PubMed ID: 33039333
[TBL] [Abstract][Full Text] [Related]
44. The clinicopathologic correlates of cellular atypia in urinary cytology of ileal neobladders.
Cimino-Mathews A; Ali SZ
Acta Cytol; 2011; 55(5):449-54. PubMed ID: 21986173
[TBL] [Abstract][Full Text] [Related]
45. The role of urinary cytology for detection of bladder cancer.
Planz B; Jochims E; Deix T; Caspers HP; Jakse G; Boecking A
Eur J Surg Oncol; 2005 Apr; 31(3):304-8. PubMed ID: 15780568
[TBL] [Abstract][Full Text] [Related]
46. Changes in specimen preparation method may impact urine cytologic evaluation.
Voss JS; Kipp BR; Krueger AK; Clayton AC; Halling KC; Karnes RJ; Henry MR; Sebo TJ
Am J Clin Pathol; 2008 Sep; 130(3):428-33. PubMed ID: 18701417
[TBL] [Abstract][Full Text] [Related]
47. Cytokeratin-20 immunocytochemistry in voided urine cytology and its comparison with nuclear matrix protein-22 and urine cytology in the detection of urothelial carcinoma.
Srivastava R; Arora VK; Aggarwal S; Bhatia A; Singh N; Agrawal V
Diagn Cytopathol; 2012 Sep; 40(9):755-9. PubMed ID: 22888081
[TBL] [Abstract][Full Text] [Related]
48. Use of mailed urine specimens in diagnosing urothelial carcinoma by cytology and DNA image analysis.
Liu J; Katz R; Shin HJ; Johnston DA; Zhang HZ; Caraway NP
Acta Cytol; 2005; 49(2):157-62. PubMed ID: 15839620
[TBL] [Abstract][Full Text] [Related]
49. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens.
Cheng L; Reiter RE; Jin Y; Sharon H; Wieder J; Lane TF; Rao J
J Urol; 2003 Jun; 169(6):2094-100. PubMed ID: 12771726
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors.
Jovanovic M; Soldatovic I; Janjic A; Vuksanovic A; Dzamic Z; Acimovic M; Hadzi-Djokic J
Urol Int; 2011; 87(2):134-7. PubMed ID: 21865670
[TBL] [Abstract][Full Text] [Related]
51. Fractionated urinary cytology in the follow-up of bladder cancer.
Hastie KJ; Ahmad R; Moisey CU
Br J Urol; 1990 Jul; 66(1):40-1. PubMed ID: 2393798
[TBL] [Abstract][Full Text] [Related]
52. [Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer].
Kitsukawa S; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T; Matsumoto T; Aizawa T; Noda K; Ito T
Hinyokika Kiyo; 2006 Mar; 52(3):167-72. PubMed ID: 16617867
[TBL] [Abstract][Full Text] [Related]
53. Dysplastic squamous cells are frequently present in urine cytology specimens of patients with high-grade urothelial carcinoma.
Sojitra P; Venkataraman G; Masoom S; Kapur U; Wojcik EM
Acta Cytol; 2012; 56(4):408-12. PubMed ID: 22846853
[TBL] [Abstract][Full Text] [Related]
54. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma.
Badalament RA; Hermansen DK; Kimmel M; Gay H; Herr HW; Fair WR; Whitmore WF; Melamed MR
Cancer; 1987 Oct; 60(7):1423-7. PubMed ID: 3304614
[TBL] [Abstract][Full Text] [Related]
55. Voided urinary cytology in bladder cancer: is it time to review the indications?
Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
[TBL] [Abstract][Full Text] [Related]
56. The dilemma of suspicious urine cytology in patients being followed for bladder cancer.
Raitanen MP; Aine R; Kylmälä T; Kallio J; Liukkonen T; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):256-9. PubMed ID: 11820413
[TBL] [Abstract][Full Text] [Related]
57. A 20-year and 46,000-specimen journey to Paris reveals the influence of reporting systems and passive peer feedback on pathologist practice patterns.
VandenBussche CJ; Allison DB; Gupta M; Ali SZ; Rosenthal DL
Cancer Cytopathol; 2018 Jun; 126(6):381-389. PubMed ID: 29757495
[TBL] [Abstract][Full Text] [Related]
58. Quantitative cytology on bladder wash versus voided urine: a comparison of results.
Moonen PM; Peelen P; Kiemeney LA; Boon ME; Schalken JA; Witjes JA
Eur Urol; 2006 Jun; 49(6):1044-9; discussion 1049-50. PubMed ID: 16527392
[TBL] [Abstract][Full Text] [Related]
59. [Urinary cytology for carcinoma of the urinary bladder].
Nagumo S; Matuda M; Kuroda M
Rinsho Byori; 1992 Jul; 40(7):728-35. PubMed ID: 1507491
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic value of positive urinary cytology in the detection of recurrent urothelial carcinoma: 10-Year Experience at the Papanicolaou Cytology Laboratory.
Shanmugam V; Geraghty B; DeSimone RA; Hoda RS
Diagn Cytopathol; 2016 Dec; 44(12):975-979. PubMed ID: 27665730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
